Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sEphB4-HSA in Kaposi Sarcoma
NCT02799485Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Feb 2018
- Primary completion
- Feb 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sephb4-hsa in Kaposi sarcoma (KS), sponsored by AIDS Malignancy Consortium. Started Feb 2018; status: completed.
02
Drugs
sephb4-hsa
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT02799485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799485.